Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.

Abstract:

BACKGROUND:To assess the safety and efficacy of simultaneous integrated boost (SIB) or late course accelerated boost (LCAB) with external beam radiotherapy (EBRT) to the vaginal cuff for high risk cervical cancer patients after radical hysterectomy. METHODS:Between October 2009 and January 2012, patients with high risk cervical cancer who had undergone radical surgery followed by EBRT to the vaginal cuff were enrolled. Patients were treated with either intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) with SIB (arm A) or IMRT/VMAT to the pelvis followed by LCAB (arm B) to vaginal cuff. In arm A, the pelvic and boost doses were 50.4 Gy and 60.2 Gy in 28 fractions, respectively. In arm B, pelvic irradiation to 50 Gy in 25 fractions followed by a boost of 9 Gy in 3 fractions were delivered. Chemotherapy was given concurrently. RESULTS:Overall, 80 patients were analyzed in this study (42 in arm A, 38 in arm B). In arm A and B, median follow-up was 37 and 32 months, respectively. The 3-year disease-free survival and overall survival in arms A vs B were 88.7% vs. 93.4% (p = 0.89), and 91.8% vs.100% (p = 0.21), respectively. The 3-year local-regional control and distant failure were 97.6% vs. 100% (p = 0.34), and 4.8% vs. 5.3% (p = 0.92), respectively. Grade 3-4 acute leukopenia and dermatitis were seen in 11 (26.2%) and 8 (19.0%) patients in Arm A, vs. 7 (17.8%) and 6 (15.8%) patients in Arm B, respectively (p > 0.05). Only Grade 1-2 chronic gastrointestinal (GI) and genitourinary (GU) toxicities were observed. CONCLUSIONS:Our results indicate that both SIB and LCAB to vaginal cuff for high risk cervical cancer patients after radical hysterectomy are associated with excellent survival, local control and low toxicity.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Wang X,Zhao Y,Shen Y,Shu P,Li Z,Bai S,Xu F

doi

10.1186/s12885-015-1248-3

subject

Has Abstract

pub_date

2015-04-11 00:00:00

pages

257

issn

1471-2407

pii

10.1186/s12885-015-1248-3

journal_volume

15

pub_type

杂志文章
  • Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.

    abstract:BACKGROUND:Crosstalk between malignant hepatocytes and the surrounding peritumoral stroma is a key modulator of hepatocarcinogenesis and therapeutic resistance. To examine the chemotherapy resistance of these two cellular compartments in vitro, we evaluated a well-established hepatic tumor cell line, HepG2, and an adul...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-402

    authors: Rangwala F,Williams KP,Smith GR,Thomas Z,Allensworth JL,Lyerly HK,Diehl AM,Morse MA,Devi GR

    更新日期:2012-09-10 00:00:00

  • Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.

    abstract:BACKGROUND:Colorectal-cancer is a leading cause of cancer death in the United States, and Latinos have particularly low rates of screening. Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC) is a partnership among two research institutions and a network of safety net clinics to promote...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/1471-2407-14-55

    authors: Coronado GD,Vollmer WM,Petrik A,Aguirre J,Kapka T,Devoe J,Puro J,Miers T,Lembach J,Turner A,Sanchez J,Retecki S,Nelson C,Green B

    更新日期:2014-02-26 00:00:00

  • Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation.

    abstract:BACKGROUND:Nonsynonymous mutations change the protein sequences and are frequently subjected to natural selection. The same goes for nonsense mutations that introduce pre-mature stop codons into CDSs (coding sequences). Synonymous mutations, however, are intuitively thought to be functionally silent and evolutionarily ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5572-x

    authors: Chu D,Wei L

    更新日期:2019-04-16 00:00:00

  • Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia.

    abstract:BACKGROUND:At present pathogenic mechanisms of cancer cachexia are poorly understood. Previous evidence in animal models implicates the melanocortin-4 receptor gene (MC4R) in the development of cancer cachexia. In humans, MC4R mutations that lead to an impaired receptor function are associated with obesity; in contrast...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-85

    authors: Knoll S,Zimmer S,Hinney A,Scherag A,Neubauer A,Hebebrand J

    更新日期:2008-03-31 00:00:00

  • The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.

    abstract:BACKGROUND:Neuroendocrine tumors (NETs) of the esophagus are extremely rare, and few cases have been reported worldwide. Thus, a comprehensive nationwide study is needed to understand the characteristics of and treatment strategy for esophageal NETs. METHODS:We collected data on esophageal NET patients from 25 hospita...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-569

    authors: Lee CG,Lim YJ,Park SJ,Jang BI,Choi SR,Kim JK,Kim YT,Cho JY,Yang CH,Chun HJ,Song SY,Neuroendocrine tumor study group.

    更新日期:2014-08-07 00:00:00

  • Smokers' interest in a lung cancer screening programme: a national survey in England.

    abstract:BACKGROUND:Following the recommendation of lung cancer screening in the US, screening committees in several European countries are reviewing the evidence for implementing national programmes. However, inadequate participation from high-risk groups poses a potential barrier to its effectiveness. The present study examin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4430-6

    authors: Quaife SL,Vrinten C,Ruparel M,Janes SM,Beeken RJ,Waller J,McEwen A

    更新日期:2018-05-02 00:00:00

  • Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer.

    abstract:BACKGROUND:Lymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers. We aimed to develop a scoring system for stratifying LVI risk in patients with breast cancer. METHODS:A total of 301 consecutive patients (mean age, 49.8 ± 11.0 years; range, 29-86 years) with breast cancer confirmed by patho...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6578-0

    authors: Ni-Jia-Ti MY,Ai-Hai-Ti DL,Huo-Jia AS,Wu-Mai-Er PL,A-Bu-Li-Zi AB,Shi Y,Rou-Zi NE,Su WJ,Dai GZ,Da-Mo-la MH

    更新日期:2020-02-03 00:00:00

  • Health profiles of 996 melanoma survivors: the M. D. Anderson experience.

    abstract:BACKGROUND:The incidence and survival of melanoma are increasing, but little is known about its long-term health effects in adult survivors. METHODS:A health survey was available from 996 melanoma survivors (577 treated with surgery alone, and 391 with combined treatments). Their medical/physiologic and psychosocial r...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-95

    authors: Stava C,Beck M,Weiss LT,Lopez A,Vassilopoulou-Sellin R

    更新日期:2006-04-18 00:00:00

  • Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer.

    abstract:BACKGROUND:We investigated the role of the HIPK2-p53 signaling pathway in tumorigenesis and resistance to the drug Verbascoside (VB) in colorectal cancer (CRC), using in vivo and in vitro experiments. METHODS:Primary human CRC samples and normal intestinal tissues from patients were analyzed for HIPK2 expression by im...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-747

    authors: Zhou L,Feng Y,Jin Y,Liu X,Sui H,Chai N,Chen X,Liu N,Ji Q,Wang Y,Li Q

    更新日期:2014-10-05 00:00:00

  • Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer.

    abstract:BACKGROUND:Borderline resectable pancreatic cancer (BRPC) is frequently associated with positive surgical margins and a poor prognosis because the tumor is in contact with major vessels. This study evaluated the relationship between the margin-negative (R0) resection rate and findings indicating peripancreatic vascular...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07698-0

    authors: Yasuta S,Kobayashi T,Aizawa H,Takahashi S,Ikeda M,Konishi M,Kojima M,Kuno H,Uesaka K,Morinaga S,Miyamoto A,Toyama H,Takakura N,Sugimachi K,Takayama W

    更新日期:2020-12-02 00:00:00

  • Barriers and facilitators to smoking cessation in a cancer context: A qualitative study of patient, family and professional views.

    abstract:BACKGROUND:Continued smoking after cancer adversely affects quality of life and survival, but one fifth of cancer survivors still smoke. Despite its demands, cancer presents an opportunity for positive behaviour change. Smoking often occurs in social groups, therefore interventions which target families and individuals...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3344-z

    authors: Wells M,Aitchison P,Harris F,Ozakinci G,Radley A,Bauld L,Entwistle V,Munro A,Haw S,Culbard B,Williams B

    更新日期:2017-05-19 00:00:00

  • EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer.

    abstract:BACKGROUND:Epidermal growth factor receptor exon 20 insertion (EGFRex20ins) mutations represent approximately 4-12% of EGFR mutations and are generally refractory to the 1st and 2nd generation EGFR tyrosine kinase inhibitors (TKIs). Development of effective therapies for patients with EGFRex20ins mutant non-small-cell ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5820-0

    authors: Fang W,Huang Y,Hong S,Zhang Z,Wang M,Gan J,Wang W,Guo H,Wang K,Zhang L

    更新日期:2019-06-17 00:00:00

  • Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.

    abstract:BACKGROUND:Helicobacter pylori (H. pylori) is thought to have an oncogenic effect on the development of gastric malignancies. However, the effect of H. pylori status on the prognosis of gastric diffuse large B-cell lymphoma (DLBCL) remains unconfirmed. This study aimed to identify the prognostic importance of H. pylori...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6067-5

    authors: Cheng Y,Xiao Y,Zhou R,Liao Y,Zhou J,Ma X

    更新日期:2019-08-28 00:00:00

  • Time trends in socioeconomic inequalities in cancer mortality: results from a 35 year prospective study in British men.

    abstract:BACKGROUND:Socioeconomic inequalities in cancer mortality in Britain have been shown to be present in the 1990s and early 2000s. Little is known about on-going patterns in such inequalities in cancer mortality. We examined time trends in socioeconomic inequalities in cancer mortality in Britain between 1978 and 2013. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-474

    authors: Ramsay SE,Morris RW,Whincup PH,Papacosta AO,Lennon LT,Wannamethee SG

    更新日期:2014-06-30 00:00:00

  • Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).

    abstract:BACKGROUND:Preoperative chemoradiotherapy (CRT), the current standard of care for locally advanced rectal cancer (LARC), is associated with many radiotherapy (RT)-related side effects. We aimed to evaluate whether S-1 and oxaliplatin (SOX) or folinic acid, 5-FU, and oxaliplatin (mFOLFOX6) can be as effective as neoadju...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07766-5

    authors: Miwa K,Oki E,Enomoto M,Ihara K,Ando K,Fujita F,Tominaga M,Mori S,Nakayama G,Shimokawa M,Saeki H,Baba H,Mori M,Akagi Y

    更新日期:2021-01-05 00:00:00

  • Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.

    abstract:BACKGROUND:Multidrug resistance (MDR) is a phenomenon that is often associated with decreased intracellular drug accumulation in patient's tumor cells resulting from enhanced drug efflux. It is related to the overexpression of a membrane protein, P-glycoprotein (Pgp-170), thereby reducing drug cytotoxicity. A variety o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-4-13

    authors: Limtrakul P,Anuchapreeda S,Buddhasukh D

    更新日期:2004-04-17 00:00:00

  • Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells.

    abstract:BACKGROUND:Cancer cells exhibit increased glycolysis for ATP production (the Warburg effect) and macromolecular biosynthesis; it is also linked with therapeutic resistance that is generally associated with compromised respiratory metabolism. Molecular mechanisms underlying radio-resistance linked to elevated glycolysis...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1368-9

    authors: Bhatt AN,Chauhan A,Khanna S,Rai Y,Singh S,Soni R,Kalra N,Dwarakanath BS

    更新日期:2015-05-01 00:00:00

  • Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.

    abstract:BACKGROUND:BRCA1 and BRCA2 mutations explain approximately one-fifth of the inherited susceptibility in high-risk Finnish hereditary breast and ovarian cancer (HBOC) families. EMSY is located in the breast cancer-associated chromosomal region 11q13. The EMSY gene encodes a BRCA2-interacting protein that has been implic...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3488-x

    authors: Määttä KM,Nurminen R,Kankuri-Tammilehto M,Kallioniemi A,Laasanen SL,Schleutker J

    更新日期:2017-07-24 00:00:00

  • Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.

    abstract:BACKGROUND:Glioblastomas (GBMs) are highly malignant brain tumours with a poor prognosis, and current cytotoxic regimens provide only a limited survival benefit. The PI3K/Akt/mTOR pathway has been an attractive target for therapy due to its high activation in GBMs as well as other cancers. The dual pan-PI3K/mTOR kinase...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2712-4

    authors: Netland IA,Førde HE,Sleire L,Leiss L,Rahman MA,Skeie BS,Gjerde CH,Enger PØ,Goplen D

    更新日期:2016-08-19 00:00:00

  • A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.

    abstract:BACKGROUND:Patients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and ablation, to prevent tumor progression and dropout and to improve long-term outcome after transplantation. We wanted to prospectively assess feasibility of systemic ant...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/s12885-019-5760-8

    authors: Eilard MS,Andersson M,Naredi P,Geronymakis C,Lindnér P,Cahlin C,Bennet W,Rizell M

    更新日期:2019-06-11 00:00:00

  • Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.

    abstract:BACKGROUND:Survival after diagnosis is a fundamental concern in cancer epidemiology. In resource-rich settings, ambient clinical databases, municipal data and cancer registries make survival estimation in real-world populations relatively straightforward. In resource-poor settings, given the deficiencies in a variety o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2080-0

    authors: Freeman E,Semeere A,Wenger M,Bwana M,Asirwa FC,Busakhala N,Oga E,Jedy-Agba E,Kwaghe V,Iregbu K,Jaquet A,Dabis F,Yumo HA,Dusingize JC,Bangsberg D,Anastos K,Phiri S,Bohlius J,Egger M,Yiannoutsos C,Wools-Kaloustian K

    更新日期:2016-02-06 00:00:00

  • Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.

    abstract:BACKGROUND:Sentinel lymph node (SLN) biopsy is an effective tool for axillary staging in patients with invasive breast cancer. This procedure has been recently proposed as part of the treatment for patients with ductal carcinoma in situ (DCIS), because cases of undetected invasive foci and nodal metastases occasionally...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-28

    authors: Zavagno G,Carcoforo P,Marconato R,Franchini Z,Scalco G,Burelli P,Pietrarota P,Lise M,Mencarelli R,Capitanio G,Ballarin A,Pierobon ME,Marconato G,Nitti D

    更新日期:2005-03-11 00:00:00

  • Amplification of HER2 is a marker for global genomic instability.

    abstract:BACKGROUND:Genomic alterations of the proto-oncogene c-erbB-2 (HER-2/neu) are associated with aggressive behavior and poor prognosis in patients with breast cancer. The variable clinical outcomes seen in patients with similar HER2 status, given similar treatments, suggests that the effects of amplification of HER2 can ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-297

    authors: Ellsworth RE,Ellsworth DL,Patney HL,Deyarmin B,Love B,Hooke JA,Shriver CD

    更新日期:2008-10-14 00:00:00

  • Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.

    abstract:BACKGROUND:This study aimed to evaluate the short- and long-term outcomes after laparoscopic resection for low rectal cancer (LRC) compared with mid/high rectal cancer (M/HRC). METHODS:Patients with rectal cancer undergoing laparoscopic resection with curative intent were retrospectively reviewed between 2009 and 2015...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07255-9

    authors: Yang H,Yao Z,Cui M,Xing J,Zhang C,Zhang N,Liu M,Xu K,Tan F,Su X

    更新日期:2020-08-14 00:00:00

  • Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.

    abstract:BACKGROUND:The transcription factor nuclear factor erythroid 2-related factor 2 (NFE2L2; previously known as NRF2) is a crucial regulator of the intracellular antioxidant response. It controls the expression of genes involved in the detoxification and elimination of reactive oxidants and electrophilic agents. The role ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2840-x

    authors: Wolf B,Goebel G,Hackl H,Fiegl H

    更新日期:2016-10-22 00:00:00

  • Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis.

    abstract:BACKGROUND:The objective of this study was to describe the real-world treatment and overall survival (OS) of German patients with a diagnosis of advanced non-small cell lung cancer (aNSCLC), and to explore factors associated with the real-world mortality risk. METHODS:This was a retrospective German claims data analys...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06738-z

    authors: Hardtstock F,Myers D,Li T,Cizova D,Maywald U,Wilke T,Griesinger F

    更新日期:2020-03-30 00:00:00

  • Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.

    abstract:BACKGROUND:c-Met signaling has been implicated in oncogenesis especially in cells with c-met gene amplification. Since 20 % of gastric cancer patients show high level of c-Met expression, c-Met has been identified as a good candidate for targeted therapy in gastric cancer. Herein, we report our newly synthesized c-Met ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2058-y

    authors: Park CH,Cho SY,Ha JD,Jung H,Kim HR,Lee CO,Jang IY,Chae CH,Lee HK,Choi SU

    更新日期:2016-01-22 00:00:00

  • Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility.

    abstract:BACKGROUND:Increased hemostatic activity is common in many cancer types and often causes additional complications and even death. Circumstantial evidence suggests that tissue factor pathway inhibitor-1 (TFPI) plays a role in cancer development. We recently reported that downregulation of TFPI inhibited apoptosis in a b...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-357

    authors: Stavik B,Skretting G,Aasheim HC,Tinholt M,Zernichow L,Sletten M,Sandset PM,Iversen N

    更新日期:2011-08-17 00:00:00

  • Seeking healthcare at their 'right' time; the iterative decision process for women with breast cancer.

    abstract:BACKGROUND:About 85% of breast cancer patients attending Komfo Anokye Teaching Hospital (KATH), Ghana, present with stage III/IV disease. In spite of great investments into the early diagnosis and management of breast cancer, late presentation persists and poses a barrier to realising the possible benefits of the gains...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07520-x

    authors: Agbeko AE,Arthur J,Bayuo J,Kaburi BB,Kyei I

    更新日期:2020-10-19 00:00:00

  • Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.

    abstract:BACKGROUND:Appropriate assessment is essential for the management of chemotherapy-induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is high on the list of causes of distress for cancer patients. However, objective assessment by medical staff makes it easy to underestimate ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6113-3

    authors: Kanda K,Fujimoto K,Mochizuki R,Ishida K,Lee B

    更新日期:2019-09-10 00:00:00